Fused heterocyclic compounds as GPR120 agonists

US10214521B2 · kind B2 · utility

Assignee

• PIRAMAL ENTERPRISES LIMITED · IN

Inventors

• Sanjay Kumar · Moraga, US
• Rajiv Sharma · Mumbai, IN
• Sangameshwar Prabhakar Sawargave · Mumbai, IN
• Vishal A. MAHAJAN · Thane, IN

Key dates

• Filing date: Sep 9, 2015
• Grant date: Feb 26, 2019
• Expiry date: Sep 9, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/048
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to fused heterocyclic compound of Formula (I), a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N-oxide, S-oxide, or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comprising said compounds; and their use for the treatment of the diseases or disorders mediated by GPR120 receptor.